The Department of Pharmaceuticals has envisaged an investment Rs 3,000 crore to set up ten more National Institute of Pharmaceutical Education and Research (NIPER) over the next five years in to enhance availability of skilled human resources in the pharma sector.
The proposal to set up ten additional NIPERs is one of the many proposals, worth Rs 12,280 crore, that have been submitted to the Planning Commission by the Department of Pharmaceuticals (DoP) under the 12th Five Year Plan.
"One of the proposals is to set up ten more NIPERs. We have submitted the proposals to the Planning Commission. Now, how many proposals are accepted is their take," Department of Pharmaceuticals Joint Secretary Devendra Chaudhry told PTI.
DoP intends to invest Rs 3,000 crore to set up the ten NIPERS and the locations for the same would be finalised only after the acceptance of proposals by Planning Commission, Chaudhry said.
The government has already set up six NIPERs at Patna, Hyderabad, Ahmedabad, Rae Bareli, Guwahati and Kolkata.
Commenting on the proposals submitted to the Planning Commission, Chaudhry said "these will help to strengthen industry, human resources, R&D, regulatory organisations and also to strengthen DoP,".
Giving details of the plan, he said part of the amount would be given as loans to the small and medium enterprises to help them achieve standards of various regulators, including the US Food and Drug Administration (USFDA).
"Some of the amount would also be utilised to help Indian companies to develop products for export markets," he said.
The DoP has also proposed to invest Rs 200 crore over the next five years to strengthen the 'Jan Aushadhi' scheme. As part of the campaign, the department would spread awareness regarding the usage of unbranded drugs, Chaudhry added.
Cheaper unbranded generic medicines have been made available through Jan Aushadhi stores. Currently, 107, such stores have been opened in various states in the country.
The department has also proposed to set up Good Laboratory Practices (GLP) compliant chemical, biological laboratories and large animal facilities in Public Private Partnership mode.
"In all this, industry needs to come out strongly and equitably for participation," Chaudhry said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
